Linked Life Data

1701702

Source:http://linkedlifedata.com/resource/pubmed/id/1701702

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1991-1-31
pubmed:abstractText
The intraventricular administration of morphine results in lesser systemic side effects, with an extremely satisfactorily pain relief going along with it (2, 5, 6). The subcutaneous pump which administers morphine intraventricularly is an interesting, non-destructive alternative of medium-term pain therapy for patients suffering from incurable pain caused by a malignant tumor in the oropharyngeal region. The morphine pump even makes it possible to go through terminal stages of the malignant disease well-relieved and in the familiar environment at home.
pubmed:language
ger
pubmed:journal
pubmed:citationSubset
D
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0012-1029
pubmed:author
pubmed:issnType
Print
pubmed:volume
45
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
53-5
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
1990
pubmed:articleTitle
[Intrathecal morphine administration for oral and maxillofacial malignomas].
pubmed:affiliation
Neurochirurgische Universitatsklinik, Bonn.
pubmed:publicationType
Journal Article, English Abstract